JACC Podcast
Ein Podcast von American College of Cardiology
1719 Folgen
-
Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Heart Failure: a EMPEROR Validation Cohort
Vom: 4.11.2024 -
JACC - November 12, 2024 Issue Summary
Vom: 4.11.2024 -
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs. Second-Generation DES: TARGET-IV NA Trial
Vom: 30.10.2024 -
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial
Vom: 30.10.2024 -
Drug-Coated Balloon Angioplasty Of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial
Vom: 28.10.2024 -
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD
Vom: 28.10.2024 -
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Vom: 28.10.2024 -
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
Vom: 28.10.2024 -
Standard of Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
Vom: 28.10.2024 -
Family Screening in Hypertrophic Cardiomyopathy - Identification of Relatives with Low Yield from Systematic Follow-up
Vom: 28.10.2024 -
JACC - November 5, 2024 Issue Summary
Vom: 28.10.2024 -
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
Vom: 28.10.2024 -
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy
Vom: 28.10.2024 -
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry
Vom: 27.10.2024 -
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-year Outcomes From the TRILUMINATE Randomized Cohort
Vom: 27.10.2024 -
Aspirin Hypersensitivity in Patients with Atherosclerotic Cardiovascular Disease
Vom: 21.10.2024 -
JACC - October 29, 2024 Issue Summary
Vom: 21.10.2024 -
Asymptomatic versus symptomatic hypotension with sacubitril/valsartan in heart failure and reduced ejection fraction in PARADIGM-HF
Vom: 21.10.2024 -
The IRONMAN trial of intravenous iron for heart failure. Adjudication of hospitalizations and deaths.
Vom: 21.10.2024 -
FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
Vom: 21.10.2024
Each week, Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition from the Journal of the American College of Cardiology (JACC), as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer-reviewed journals in the world for scientific impact.
